The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

PLINK: a tool set for whole-genome association and population-based linkage analyses.

Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · see citing works

Inference of Population Structure Using Multilocus Genotype Data

Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,871 · see citing works

GCTA: a tool for genome-wide complex trait analysis

Yang, J., Lee, S. H., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.011 · Cited by 8,279 · see citing works

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263 · see citing works

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

The ESEMeD/MHEDEA 2000 Investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00327.x · Cited by 1,825 · see citing works

Neuregulin 1 and Susceptibility to Schizophrenia

Stefánsson, H., Pétursson, H., Sigurðsson, E., Steinthórsdóttir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,671 · see citing works

A Unified Approach to Genotype Imputation and Haplotype-Phase Inference for Large Data Sets of Trios and Unrelated Individuals

Browning, B. L., & Browning, S. R. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.005 · Cited by 1,640 · see citing works

Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study

D, M. F. M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., Thase, M. E., Sackeïm, H. A., Quitkin, F. M., Wisniewski, S. R., Lavori, P. W., Rosenbaum, J. F., et al. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00107-7 · Cited by 520 · see citing works

Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project

Uher, R., Perroud, N. A., Ng, M., Hauser, J., Henigsberg, N., Maier, W., Mors, O. N., Placentino, A., Rietschel, M., Souery, D., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09070932 · Cited by 350 · see citing works

Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder: A Meta-Analysis Including 6562 Patients

Szegedi, A., Jansen, W. T., van Willigenburg, A. P. P., van der Meulen, E., Stassen, H. H., & Thase, M. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m03780 · Cited by 341 · see citing works

A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression

Ising, M., Lucae, S., Binder, E. B., Bettecken, T., Uhr, M., Ripke, S., Kohli, M. A., Hennings, J. M., Horstmann, S., Kloiber, S. M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.95 · Cited by 306 · see citing works

Meta-analysis shows strong positive association of the neuregulin 1 ( NRG1 ) gene with schizophrenia

Li, D., Collier, D. A., & He, L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl122 · Cited by 295 · see citing works

A Genomewide Association Study of Citalopram Response in Major Depressive Disorder

Garriock, H. A., Kraft, J. B., Shyn, S. I., Peters, E. J., Yokoyama, J. S., Jenkins, G. D., Reinalda, M. S., Slager, S. L., McGrath, P. J., & Hamilton, S. P. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.029 · Cited by 288 · see citing works

Contribution of Common Genetic Variants to Antidepressant Response

Tansey, K. E., Guipponi, M., Hu, X., Domenici, E., Lewis, G., Malafosse, A., Wendland, J. R., Lewis, C. M., McGuffin, P., & Uher, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.030 · Cited by 245 · see citing works

Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies

GENDEP Investigators, MARS Investigators, STAR*D Investigators, Uher, R., Tansey, K. E., Henigsberg, N., Wolfgang, M. C., Mors, O. N., Hauser, J., Placentino, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020237 · Cited by 241 · see citing works

MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1–Cdc25 pathway

Gruber, R., Zhou, Z., Sukchev, M., Jörß, T., Frappart, P., & Wang, Z. (2011) · Nature Cell Biology · doi:10.1038/ncb2342 · Cited by 230 · see citing works

Primary Autosomal Recessive Microcephaly (MCPH1) Maps to Chromosome 8p22-pter

Jackson, A. P., McHale, D. P., Campbell, D. A., Jafri, H., Rashid, Y. A., Mannan, J., Karbani, G., Corry, P. C., Levene, M. I., Mueller, R. F., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301966 · Cited by 169 · see citing works

Facilitation of NMDAR-Independent LTP and Spatial Learning in Mutant Mice Lacking Ryanodine Receptor Type 3

Futatsugi, A., Kato, K., Ogura, H., Li, S., Nagata, E., Kuwajima, G., Tanaka, K., Itohara, S., & Mikoshiba, K. (1999) · Neuron · doi:10.1016/s0896-6273(00)81123-x · Cited by 166 · see citing works

Rates of 5 Common Antidepressant Side Effects Among New Adult and Adolescent Cases of Depression: A Retrospective US Claims Study

Anderson, H. D., Pace, W. D., Libby, A. M., West, D. R., & Valuck, R. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.024 · Cited by 147 · see citing works

Linking the SWI/SNF complex to prostate cancer

Lee, R. S., & Roberts, C. W. M. (2013) · Nature Genetics · doi:10.1038/ng.2805 · Cited by 138 · see citing works

Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation

Adasme, T., Haeger, P. A., Paula-Lima, A. C., Espinoza, I., Casas-Alarcón, M. M., Carrasco, M. A., & Hidalgo, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013580108 · Cited by 135 · see citing works

Support for the N -Methyl-D-Aspartate Receptor Hypofunction Hypothesis of Schizophrenia From Exome Sequencing in Multiplex Families

Timms, A. E., Dorschner, M. O., Wechsler, J., Choi, K. Y., Kirkwood, R., Girirajan, S., Baker, C. A., Eichler, E. E., Korvatska, O., Roche, K. W., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1195 · Cited by 133 · see citing works

Genomewide Association Analysis Followed by a Replication Study Implicates a Novel Candidate Gene for Neuroticism

van den Oord, E. J. C. G., Kuo, P., Hartmann, A. M., Webb, B. T., Möller, H., Hettema, J. M., Giegling, I., Bukszár, J., & Rujescu, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.9.1062 · Cited by 131 · see citing works

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis

Tansey, K. E., Guipponi, M., Perroud, N. A., Bondolfi, G., Domenici, E., Evans, D. M., Hall, S. K., Hauser, J., Henigsberg, N., Hu, X., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001326 · Cited by 131 · see citing works

Trajectories of Depression Severity in Clinical Trials of Duloxetine

Gueorguieva, R. V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.132 · Cited by 114 · see citing works

Support for Neuregulin 1 as a Susceptibility Gene for Bipolar Disorder and Schizophrenia

Georgieva, L., Dimitrova, A., Ivanov, D. K., Nikolov, I., Williams, N. M., Grozeva, D., Zaharieva, I. T., Toncheva, D. I., Owen, M. J., Kirov, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.025 · Cited by 109 · see citing works

Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression

Belzeaux-R, R., Formisano‐Tréziny, C., Loundou, A., Boyer, L., Gabert, J. A., Samuelian, J., Feron, F. P., Naudin, J., & Ibrahim, E. C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.011 · Cited by 95 · see citing works

Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation

Menke, A., Domschke, K., Czamara, D., Klengel, T., Hennings, J. M., Lucae, S., Baune, B. T., Arolt, V., Müller‐Myhsok, B., Holsboer, F., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.257 · Cited by 83 · see citing works

Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research

Fabbri, C., di Girolamo, G., & Serretti, A. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32184 · Cited by 82 · see citing works

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics

Ji, Y., Biernacka, J. M., Hebbring, S. J., Chai, Y., Jenkins, G. D., Batzler, A. J., Snyder, K. A., Drews, M. S., Desta, Z., Flockhart, D. A., et al. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.32 · Cited by 77 · see citing works

Properties of Ryr3 Ryanodine Receptor Isoform in Mammalian Brain

Murayama, T., & Ogawa, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5079 · Cited by 74 · see citing works

Subchronic Peripheral Neuregulin-1 Increases Ventral Hippocampal Neurogenesis and Induces Antidepressant-Like Effects

Mahar, I., Tan, S., Davoli, M. A., Domínguez-López, S., Qiang, C., Rachalski, A., Turecki, G., & Mechawar, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026610 · Cited by 59 · see citing works

A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder

Bacchelli, E., Ceroni, F., Pinto, D., Lomartire, S., Giannandrea, M., D’Adamo, P., Bonora, E., Parchi, P., Tancredi, R., Battaglia, A., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-17 · Cited by 58 · see citing works

An analysis of candidate autism loci on chromosome 2q24–q33: Evidence for association to the STK39 gene

Ramoz, N., Cai, G., Reichert, J. G., Silverman, J. M., & Buxbaum, J. D. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30739 · Cited by 55 · see citing works

Treatment Outcomes of Depression

Mrazek, D. A., Biernacka, J. M., McAlpine, D. E., Benitez, J., Karpyak, V. M., Williams, M. D., Hall‐Flavin, D. K., Netzel, P. J., Passov, V., Rohland, B. M., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000099 · Cited by 48 · see citing works

Genome-wide association studies of antidepressant outcome: A brief review

Laje, G., & McMahon, F. J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.031 · Cited by 47 · see citing works

Copy number changes of the microcephalin 1 gene (MCPH1) in patients with autism spectrum disorders

Özgen, M. H., van Daalen, E., Bolton, P., Maloney, V. K., Huang, S., Cresswell, L., van den Boogaard, M. H., Eleveld, M. J., Slot, R. V. ‘., Hochstenbach, R., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01254.x · Cited by 45 · see citing works

Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review

Tang, S. W., Helmeste, D. M., & Leonard, B. E. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.639800 · Cited by 42 · see citing works

Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine

Wang, N., Zhang, G.-F., Liu, X.-Y., Sun, H.-L., Wang, X.-M., Qiu, L.-L., Yang, C., & Yang, J.-J. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0277-8 · Cited by 41 · see citing works

Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci

Oldmeadow, C. J., Mossman, D., Evans, T., Holliday, E. G., Tooney, P. A., Cairns, M. J., Wu, J. Q., Carr, V. J., Attia, J., & Scott, R. J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.01.011 · Cited by 41 · see citing works

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

Bousman, C. A., Yung, A. R., Pantelis, C., Ellis, J. A., Chavez, R. A., Nelson, B., Lin, A., Wood, S. J., Amminger, G. P., Velakoulis, D., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.23 · Cited by 38 · see citing works

A comparison of antidepressant use in Nova Scotia, Canada and Australia

Smith, A. J., SKETRIS, I. S., Cooke, C., Gardner, D. M., Kisely, S. R., & Tett, S. E. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1541 · Cited by 35 · see citing works

Predicting Treatment Response in Major Depressive Disorder: The Impact of Early Symptomatic Improvement

Kudlow, P. A., Cha, D. S., & Mclntyre, R. S. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205701211 · Cited by 32 · see citing works

Predicting Response to Psychopharmacological Treatment: Survey of Recent Results

Stassen, H. H., Anghelescu, I.-G., Angst, J., Böker, H., Lötscher, K., Rujescu, D., Szegedi, A., & Scharfetter, C. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286290 · Cited by 26 · see citing works

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression

Kurose, K., Hiratsuka, K., Ishiwata, K., Nishikawa, J., Nonen, S., Azuma, J., Kato, M., Wakeno, M., Okugawa, G., Kinoshita, T., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.01.023 · Cited by 25 · see citing works

Epigenetic Silencing of Stk39 in B-Cell Lymphoma Inhibits Apoptosis from Genotoxic Stress

Balatoni, C. E., Dawson, D. W., Suh, J., Sherman, M. H., Sanders, G., Hong, J. S., Frank, M. J., Malone, C. S., SAID, J. W., & Teitell, M. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090091 · Cited by 23 · see citing works

Evidence for associations between MDGA2 polymorphisms and harm avoidance – replication and extension of a genome-wide association finding

Heck, A., Pfister, H., Czamara, D., Müller‐Myhsok, B., Pütz, B., Lucae, S., Hennings, J. M., & Ising, M. (2011) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283457bfb · Cited by 15 · see citing works

Antidepressants, age, and neuroprogenitors

Boldrini, M., & Arango, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.130 · Cited by 13 · see citing works

Association of microcephalin 1, syntrophin‐beta 1, and other genes with automatic thoughts in the Japanese population

Ishitobi, Y., Inoue, A., Aizawa, S., Masuda, K., Ando, T., Kawano, A., Ikeda, R., Maruyama, Y., Kanehisa, M., Ninomiya, T., et al. (2014) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32252 · Cited by 6 · see citing works

Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions

Howard, D. M., Adams, M. J., Clarke, T.-K., Hafferty, J. D., Gibson, J., Shirali, M., Coleman, J. R. I., Hagenaars, S. P., Ward, J., Wigmore, E. M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0326-7 · Cited by 2,565 · see citing works

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

Hiemke, C., Bergemann, N., Clement, H. ‐., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K. M., Gerlach, M., Greiner, C., et al. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,466 · see citing works

Review and Consensus on Pharmacogenomic Testing in Psychiatry

Bousman, C., Bengesser, S., Aitchison, K. J., Amare, A. T., Aschauer, H. N., Baune, B. T., Asl, B. B., Bishop, J. R., Burmeister, M., Chaumette, B., et al. (2020) · Pharmacopsychiatry · doi:10.1055/a-1288-1061 · Cited by 213 · see citing works

Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing

Zeier, Z. R., Carpenter, L. L., Kalin, N. H., Rodríguez, C. I., McDonald, W. M., Widge, A. S., & Nemeroff, C. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17111282 · Cited by 194 · see citing works

A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers

Lin, E., Kuo, P., Liu, Y.-L., Yu, Y. W. ‐., Yang, A. C., & Tsai, S. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00290 · Cited by 191 · see citing works

Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry

Amare, A. T., Schubert, K. O., & Baune, B. T. (2017) · The EPMA Journal · doi:10.1007/s13167-017-0112-8 · Cited by 129 · see citing works

Identifying the Common Genetic Basis of Antidepressant Response

Pain, O., Hodgson, K., Trubetskoy, V., Ripke, S., Marshe, V. S., Adams, M. J., Byrne, E. M., Campos, A. I., Carrillo‐Roa, T., Cattaneo, A., et al. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.07.008 · Cited by 127 · see citing works

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

Gupta, M., Neavin, D. R., Liu, D., Biernacka, J. M., Hall‐Flavin, D. K., Bobo, W. V., Frye, M. A., Skime, M. K., Jenkins, G. D., Batzler, A. J., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.6 · Cited by 119 · see citing works

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication

Athreya, A. P., Neavin, D. R., Carrillo‐Roa, T., Skime, M. K., Biernacka, J. M., Frye, M. A., Rush, A. J., Wang, L., Binder, E. B., Iyer, R. K., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1482 · Cited by 114 · see citing works

The potential of predictive analytics to provide clinical decision support in depression treatment planning

Kessler, R. C. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000377 · Cited by 103 · see citing works

Pharmacogenetics of antidepressant response: A polygenic approach

García‐González, J., Tansey, K. E., Hauser, J., Henigsberg, N., Maier, W., Mors, O. N., Placentino, A., Rietschel, M., Souery, D., Žagar, T., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.011 · Cited by 91 · see citing works

Genetic variants in major depressive disorder: From pathophysiology to therapy

Gonda, X., Petschner, P., Eszlári, N., Baksa, D., Édes, A. E., Antal, P., Juhász, G., & Bagdy, G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.002 · Cited by 88 · see citing works

Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP

Wigmore, E. M., Hafferty, J. D., Hall, L. S., Howard, D. M., Clarke, T., Fabbri, C., Lewis, C. M., Uher, R., Navrady, L. B., Adams, M. J., et al. (2019) · The Pharmacogenomics Journal · doi:10.1038/s41397-019-0067-3 · Cited by 78 · see citing works

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics

Liu, D., Ray, B., Neavin, D. R., Zhang, J., Athreya, A. P., Biernacka, J. M., Bobo, W. V., Hall‐Flavin, D. K., Skime, M. K., Zhu, H., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0056-8 · Cited by 79 · see citing works

Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables

Iniesta, R., Hodgson, K., Stahl, D. R., Malki, K., Maier, W., Rietschel, M., Mors, O. N., Hauser, J., Henigsberg, N., Dernovšek, M. Z., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23584-z · Cited by 78 · see citing works

Cohort profile: the Australian genetics of depression study

Byrne, E. M., Kirk, K. M., Medland, S. E., McGrath, J. J., Colodro‐Conde, L., Parker, R., Cross, S., Sullivan, L., Statham, D. J., Levinson, D. F., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032580 · Cited by 78 · see citing works

Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine

Nassan, M. M., Nicholson, W. T., Elliott, M. A., Vitek, C. R. R., Black, J. L., & Frye, M. A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.02.023 · Cited by 76 · see citing works

Personalized medicine: Genetic risk prediction of drug response

Zhang, G., & Nebert, D. W. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.036 · Cited by 78 · see citing works

Treatment-resistant depression: molecular mechanisms and management

Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 86 · see citing works

Prediction of response to drug therapy in psychiatric disorders

Stern, S., Linker, S. B., Vadodaria, K. C., Marchetto, M. C., & Gage, F. H. (2018) · Open Biology · doi:10.1098/rsob.180031 · Cited by 65 · see citing works

Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts

Ward, J., Graham, N., Strawbridge, R. J., Ferguson, A., Jenkins, G. D., Chen, W., Hodgson, K., Frye, M. A., Weinshilboum, R. M., Uher, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203896 · Cited by 63 · see citing works

Predicting treatment outcome in depression: an introduction into current concepts and challenges

Rost, N., Binder, E. B., & Brückl, T. M. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01418-4 · Cited by 58 · see citing works

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder

Amare, A., Schubert, K., Tekola-Ayele, F., Hsu, Y., Sangkuhl, K., Jenkins, G., Whaley, R., Barman, P., Batzler, A., Altman, R., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00065 · Cited by 47 · see citing works

Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study

Schiele, M. A., Zwanzger, P., Schwarte, K., Arolt, V., Baune, B. T., & Domschke, K. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa081 · Cited by 47 · see citing works

The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response Study: Design and Methodology

Kang, H., Kim, J., Kim, S. Y., Kim, S., Shin, H., Shin, M., & Kim, J. (2018) · Psychiatry Investigation · doi:10.30773/pi.2017.10.2 · Cited by 50 · see citing works

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

Fabbri, C., Tansey, K. E., Perlis, R. H., Hauser, J., Henigsberg, N., Maier, W., Mors, O. N., Placentino, A., Rietschel, M., Souery, D., et al. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.44 · Cited by 49 · see citing works

Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe

Pinzón-Espinosa, J., van der Horst, M. Z., Zinkstok, J., Austin, J., Aalfs, C. M., Batalla, A., Sullivan, P. F., Vorstman, J. A. S., & Luykx, J. J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02203-6 · Cited by 49 · see citing works

Ensemble Learning for Early‐Response Prediction of Antidepressant Treatment in Major Depressive Disorder

Pei, C., Sun, Y., Zhu, J., Wang, X., Zhang, Y., Zhang, S., Yao, Z., & Lü, Q. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27029 · Cited by 47 · see citing works

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance

Fabbri, C., Corponi, F., Albani, D., Raimondi, I., Forloni, G., Schruers, K. R. J., Kasper, S. F., Kautzky, A., Zohar, J., Souery, D., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.005 · Cited by 47 · see citing works

Pharmacogenetics in Psychiatry

Corponi, F., Fabbri, C., & Serretti, A. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.03.003 · Cited by 47 · see citing works

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression

Amare, A. T., Schubert, K. O., Ayele, F. T., Hsu, Y., Sangkuhl, K., Jenkins, G. D., Whaley, R. M., Barman, P., Batzler, A. J., Altman, R. B., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-018-01966-x · Cited by 46 · see citing works

Dysregulation of Neuregulin-1/ErbB signaling in the prefrontal cortex and hippocampus of rats exposed to chronic unpredictable mild stress

Dang, R., Cai, H., Zhang, L., Liang, D., Lv, C., Guo, Y., Yang, R., Zhu, Y., & Jiang, P. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.11.023 · Cited by 45 · see citing works

Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies

Fabbri, C., & Serretti, A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.020 · Cited by 42 · see citing works

How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry

Koch, E. M., Pardiñas, A. F., O’Connell, K. S., Selvaggi, P., Camacho-Collados, J., Babić, A., Marshall, S., der Eycken, E. V., Angulo, C., Lu, Y., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.01.001 · Cited by 45 · see citing works

Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records

Tasa, T., Krebs, K., Kals, M., Mägi, R., Lauschke, V. M., Haller, T., Puurand, T., Remm, M., Esko, T., Metspalu, A., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0300-6 · Cited by 41 · see citing works

Progress and prospects in pharmacogenetics of antidepressant drugs

Fabbri, C., Crisafulli, C., Calabrò, M., Spina, E., & Serretti, A. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1202237 · Cited by 37 · see citing works

Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder

Paroni, G., Seripa, D., Fontana, A., D’Onofrio, G., Gravina, C., Urbano, M., Addante, F., Lozupone, M., Copetti, M., Pilotto, A., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9711-y · Cited by 36 · see citing works

Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity

Carrillo‐Roa, T., Labermaier, C., Weber, P. C., Herzog, D. P., Lareau, C. A., Santarelli, S., Wagner, K. V., Rex‐Haffner, M., Harbich, D., Scharf, S. H., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002690 · Cited by 35 · see citing works

Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder

Bobo, W. V., Ommeren, B. V., & Athreya, A. P. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2112949 · Cited by 36 · see citing works

Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis

Li, D., Pain, O., Fabbri, C., Wong, W. L. E., Lo, C. W. H., Ripke, S., Cattaneo, A., Souery, D., Dernovšek, M. Z., Henigsberg, N., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02981-1 · Cited by 37 · see citing works

Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings

Athreya, A. P., Brückl, T. M., Binder, E. B., Rush, A. J., Biernacka, J. M., Frye, M. A., Neavin, D. R., Skime, M. K., Monrad, D., Iyer, R. K., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00943-x · Cited by 33 · see citing works

Right patient, right treatment, right time: biosignatures and precision medicine in depression

Trivedi, M. H. (2016) · World Psychiatry · doi:10.1002/wps.20371 · Cited by 32 · see citing works

Pharmacogenetics and Depression: A Critical Perspective

Corponi, F., Fabbri, C., & Serretti, A. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.06.16 · Cited by 32 · see citing works

Predisposition to treatment response in major depressive episode: A peripheral blood gene coexpression network analysis

Belzeaux-R, R., Lin, C., Ding, Y., Bergon, A., Ibrahim, E. C., Turecki, G., Tseng, G. C., & Sibille, E. L. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.009 · Cited by 31 · see citing works

The laterodorsal tegmentum-ventral tegmental area circuit controls depression-like behaviors by activating ErbB4 in DA neurons

Wang, H., Cui, W., Chen, W., Liu, F., Dong, Z., Xing, G., Luo, B., Gao, N., Zou, W.-J., Zhao, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01137-7 · Cited by 32 · see citing works

Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression

Carboni, L., Marchetti, L., Lauria, M., Gass, P., Vollmayr, B., Redfern, A. J., Jones, L., Razzoli, M., Malki, K., Begni, V., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0117-6 · Cited by 30 · see citing works

Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients

Kao, C.-F., Liu, Y.-L., Yu, Y. W. ‐., Yang, A. C., Lin, E., Kuo, P., & Tsai, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-25529-y · Cited by 30 · see citing works

Genetic epidemiology of depression in the molecular era

Merikangas, A. K., & Merikangas, K. R. (2020) · doi:10.1093/med/9780198713005.003.0075 · Cited by 29 · see citing works

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway

Cocchi, E., Fabbri, C., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., Pae, C., & Serretti, A. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0813-x · Cited by 29 · see citing works

Heterogeneous stock rats: a model to study the genetics of despair‐like behavior in adolescence

Holl, K., He, H., Wedemeyer, M. J., Clopton, L., Wert, S. L., Meckes, J. K., Cheng, R., Kastner, A., Palmer, A. A., Redei, E. E., et al. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12410 · Cited by 27 · see citing works

ERICH3: vesicular association and antidepressant treatment response

Liu, D., Zhuang, Y., Zhang, L., Gao, H., Neavin, D. R., Carrillo‐Roa, T., Wang, Y., Yu, J., Qin, S., Kim, D. C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00940-y · Cited by 27 · see citing works

Toward a Global Roadmap for Precision Medicine in Psychiatry: Challenges and Opportunities

Dalvie, S., Koen, N., McGregor, N. W., O’Connell, K. S., Warnich, L., Ramesar, R., Nievergelt, C. M., & Stein, D. J. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0110 · Cited by 27 · see citing works

Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk

Srivastava, A., Singh, P., Gupta, H., Kaur, H., Kanojia, N., Guin, D., Sood, M., Chadda, R. K., Yadav, J., Vohora, D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081993 · Cited by 26 · see citing works

Molecular serum signature of treatment resistant depression

Ruland, T., Chan, M. K., Stocki, P., Grosse, L., Rothermundt, M., Cooper, J. D., Arolt, V., & Bahn, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4348-0 · Cited by 26 · see citing works

Patient-Driven Privacy Control through Generalized Distillation

Celik, Z. B., López-Paz, D., & McDaniel, P. D. (2017) · IEEE Symposium on Privacy-Aware Computing (PAC) · doi:10.1109/pac.2017.13 · Cited by 23 · see citing works

MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action

Oved, K., Farberov, L., Gilam, A., Israel‐Elgali, I., Haguel, D., Gurwitz, D., & Shomron, N. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00355 · Cited by 22 · see citing works

Multivariate generalized linear model for genetic pleiotropy

Schaid, D. J., Tong, X., Batzler, A. J., Sinnwell, J. P., Jiang, Q. Y., & Biernacka, J. M. (2017) · Biostatistics · doi:10.1093/biostatistics/kxx067 · Cited by 22 · see citing works

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction

Nguyen, T. T. L., Liu, D., Ho, M., Athreya, A. P., & Weinshilboum, R. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.614048 · Cited by 24 · see citing works

Pharmacogenetics of Antidiabetic Drugs

Srinivasan, S., Yee, S. W., & Giacomini, K. M. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.04.005 · Cited by 21 · see citing works

Pharmacogenomics and Biomarkers of Depression

Jha, M. K., & Trivedi, M. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_171 · Cited by 20 · see citing works

Gene-Based Association Analysis Suggests Association of HTR2A With Antidepressant Treatment Response in Depressed Patients

Kao, C.-F., Kuo, P., Yu, Y. W. ‐., Yang, A. C., Lin, E., Liu, Y.-L., & Tsai, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.559601 · Cited by 21 · see citing works

Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder

Xu, Z., Xie, C., Xia, L., Yuan, Y., Zhu, H., Huang, X., Li, C., Yu, T., Qu, X., Zhang, F., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0689-x · Cited by 19 · see citing works

Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies

Lett, T. A. P., Walter, H., & Brandl, E. J. (2016) · CNS Drugs · doi:10.1007/s40263-016-0385-9 · Cited by 18 · see citing works

Treatment of Premenstrual Dysphoric Disorder (PMDD)

Hantsoo, L. V., & Riddle, J. (2021) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2021.05.009 · Cited by 18 · see citing works

Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants

Kang, H., Kim, K., Yoo, K.-H., Park, Y., Kim, J., Kim, J., Shin, I.-S., Kim, J. H., & Kim, J. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144884 · Cited by 17 · see citing works

Treatment of Major Depressive Disorder in Pediatric Populations

Neavin, D. R., Joyce, J., & Swintak, C. C. (2018) · Diseases · doi:10.3390/diseases6020048 · Cited by 16 · see citing works

Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder

Qin, S., Eugene, A. R., Liu, D., Zhang, L., Neavin, D. R., Biernacka, J. M., Yu, J., Weinshilboum, R. M., & Wang, L. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1692 · Cited by 17 · see citing works

Early life adversity targets the transcriptional signature of hippocampal NG2+ glia and affects voltage gated sodium (Nav) channels properties

Treccani, G., Yiğit, H., Lingner, T., Schleuβner, V., Mey, F., van der Kooij, M. A., Wennström, M., Herzog, D. P., Linke, M., Fricke, M., et al. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100338 · Cited by 14 · see citing works

Genetic mechanisms of electroconvulsive therapy response in depression

Benson-Martin, J., Stein, D. J., Baldwin, D. S., & Domschke, K. (2016) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2531 · Cited by 15 · see citing works

Putative Cell Adhesion Membrane Protein Vstm5 Regulates Neuronal Morphology and Migration in the Central Nervous System

Lee, A.-R., Ko, K. W., Lee, H., Yoon, Y.-S., Song, M., & Park, C. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0541-16.2016 · Cited by 16 · see citing works

Rationale and design for a pragmatic randomized trial to assess gene‐based prescribing for SSRIs in the treatment of depression

Hines, L. J., Wilke, R. A., Myers, R. A., Mathews, C. A., Liu, M., Baye, J. F., Petry, N., Cicali, E. J., Duong, B. Q., Elwood, E. N., et al. (2024) · Clinical and Translational Science · doi:10.1111/cts.13822 · Cited by 13 · see citing works

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder

Xin, J., Yuan, M., Peng, Y., & Wang, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00151 · Cited by 13 · see citing works

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial

Strawn, J. R., Poweleit, E. A., Mills, J. A., Schroeder, H. K., Neptune, Z. A., Specht, A. M., Farrow, J. E., Zhang, X., Martin, L. J., & Ramsey, L. B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111188 · Cited by 13 · see citing works

Current progress in targeted pharmacotherapy to treat symptoms of major depressive disorder: moving from broad-spectrum treatments to precision psychiatry

Singh, M. K., & Thase, M. E. (2025) · CNS Spectrums · doi:10.1017/s1092852925000094 · Cited by 12 · see citing works

Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial

Gadad, B. S., Raj, P., Jha, M. K., Carmody, T. J., Dozmorov, I. M., Mayes, T. L., Wakeland, E. K., & Trivedi, M. H. (2018) · Complex Psychiatry · doi:10.1159/000487321 · Cited by 12 · see citing works

The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients

Chappell, K., Colle, R., Bouligand, J., Trabado, S., Fève, B., Becquemont, L., Corruble, E., & Verstuyft, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010497 · Cited by 11 · see citing works

Clinical utility of pharmacogenetics-guided treatment of depression and anxiety

Boland, J. R., Duffy, B. C., & Myer, N. M. (2017) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2017.11.001 · Cited by 11 · see citing works

Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramine

Kowalewski, C., Haen, E., Hiemke, C., Ridders, F., Endres, K., Gründer, G., Paulzen, M., & Schoretsanitis, G. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000268 · Cited by 10 · see citing works

Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership

Bousman, C., Oomen, A., Jessel, C. D., Tampi, R. R., Forester, B. P., Eyre, H. A., Lavretsky, H., & Müller, D. J. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.09.013 · Cited by 10 · see citing works

The Pharmacogenomics of Selective Serotonin Reuptake Inhibitors

García‐Marín, L. M., Rabinowitz, J. A., Ceja, Z., Alcauter, S., Medina-Rivera, A., & Rentería, M. E. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0037 · Cited by 11 · see citing works

The Australian Genetics of Depression Study: Study Description and Sample CharacteristicsPreprint

Byrne, E. M., Kirk, K. M., Medland, S. E., McGrath, J. J., Parker, R., Cross, S., Sullivan, L., Statham, D. J., Levinson, D. F., Licinio, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/626762 · Cited by 10 · see citing works

Genome-wide meta-analyses of non-response to antidepressants provide insights into underlying molecular genetics and suggest potential pharmacotherapies

Koch, E. M., Puusepp, T., Einarsson, G., Mitchell, B. L., Harder, A., Lin, Y., García‐Marín, L. M., Krebs, K., Shadrin, A. A., Xiong, Y., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03357-7 · Cited by 14 · see citing works

Whole-genome sequencing reveals KRTAP1-1 as a novel genetic variant associated with antidepressant treatment outcomes

Park, J.-H., Lim, S., Myung, W., Park, I. H., Jang, H.-J., Kim, S., Lee, M.-S., Chang, H. S., Yum, D., Suh, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83887-6 · Cited by 9 · see citing works

Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study

Fjukstad, K. K., Athanasiu, L., Bahrami, S., O’Connell, K. S., van der Meer, D., Bettella, F., Dieset, I., Steen, N. E., Djurovic, S., Spigset, O., et al. (2021) · The Pharmacogenomics Journal · doi:10.1038/s41397-021-00234-8 · Cited by 9 · see citing works

Biomarkers for Major Depressive Disorder: Economic Considerations

Bogavac‐Stanojević, N., & Lakić, D. (2016) · Drug Development Research · doi:10.1002/ddr.21330 · Cited by 8 · see citing works

Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study

CASALE, A. D., Pomes, L. M., Bonanni, L., Fiaschè, F., Zocchi, C., Padovano, A., Luca, O. D., Angeletti, G., Brugnoli, R., Girardi, P., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020316 · Cited by 8 · see citing works

Prediction of Response to Drug Therapy in Psychiatric Disorders

Stern, S., Linker, S. B., Vadodaria, K. C., Marchetto, M. C., & Gage, F. H. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17304 · Cited by 8 · see citing works

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

Andre, K., Kampman, O., Viikki, M., Setälä-Soikkeli, E., Illi, A., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.37 · Cited by 7 · see citing works

Pharmacogenomics

Nebert, D. W., & Zhang, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812537-3.00016-0 · Cited by 8 · see citing works

Pharmakogenetik in der Psychiatrie: eine Standortbestimmung

Genetik, D. D. R. N. U., Müller, D., Brandl, E. J., Degenhardt, F., Domschke, K., Grabe, H. J., Gruber, O., Hebebrand, J., Maier, W., Menke, A., et al. (2018) · Der Nervenarzt · doi:10.1007/s00115-017-0479-8 · Cited by 7 · see citing works

Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers

Singh, P., Srivastava, A., Guin, D., Thakran, S., Yadav, J., Chandna, P., Sood, M., Chadda, R. K., & Kukreti, R. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad001 · Cited by 6 · see citing works

Investigating genetic variants for treatment response to selective serotonin reuptake inhibitors in syndromal factors and side effects among patients with depression in Taiwanese Han population

Huang, S., Chen, Y.-T., Su, M., Tsai, S., Chen, H.-H., Yang, A. C., Liu, Y., & Kuo, P. (2023) · The Pharmacogenomics Journal · doi:10.1038/s41397-023-00298-8 · Cited by 6 · see citing works

Pharmacogenetic Testing of Children and Adolescents with Mental Health Conditions: Real-World Experiences

Kennedy, A., Scodellaro, S., Verstegen, R. H. J., & Cohn, I. (2025) · Pharmaceuticals · doi:10.3390/ph18081170 · Cited by 5 · see citing works

Insights into the genomics of affective disorders

Forstner, A. J., Hoffmann, P., Nöthen, M. M., & Cichon, S. (2020) · Medizinische Genetik · doi:10.1515/medgen-2020-2003 · Cited by 5 · see citing works

Identifying Genetic Loci Affecting Antidepressant Drug Response in Depression Using Drug–Gene Interaction Models

Noordam, R., Avery, C. L., Visser, L. E., & Stricker, B. H. C. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0024 · Cited by 4 · see citing works

Clinical Genomics in Physical Therapy: Where to From Here?

Cornwall, J., Elliott, J. M., Walton, D. M., & Osmotherly, P. G. (2018) · Physical Therapy · doi:10.1093/ptj/pzy069 · Cited by 4 · see citing works

Precision Medicine in Antidepressants Treatment

Tsermpini, E. E., Serretti, A., & Dolžan, V. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_654 · Cited by 4 · see citing works

Putative biological predictors of treatment response in bipolar disorders

Gonzalez, S., Williams, A. J., Blacker, C. J., Voort, J. L. V., Schak, K. M., Nemeroff, C. B., Widge, A. S., & Tohen, M. F. (2016) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.11.003 · Cited by 4 · see citing works

Pharmacogenetics of antidepressants (from history to the present)

Ilyina, E. S., Filippova, N. V., & Barylnik, Y. B. (2021) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2109-06 · Cited by 3 · see citing works

Codein: Neue Anwendungsbeschränkungen bei Kindern und Jugendlichen

Stingl, J., & Rotthauwe, J. (2015) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0041-102948 · Cited by 3 · see citing works

OPEN ORIGINAL ARTICLE

International, T., Ssri Pharmacogenomics Consortium, & Weinshilboum, R. M. (2016)

Identifying genetic loci associated with antidepressant drug response with drug–gene interaction models in a population-based study

Noordam, R., Direk, N., Sitlani, C. M., Aarts, N., Tiemeier, H. W., Albert Hofman, D., Uitterlinden, A. G., Psaty, B. M., Stricker, B. H. C., & Visser, L. E. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.01.005 · Cited by 15 · see citing works

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics

Ji, Y., Biernacka, J. M., Hebbring, S. J., Chai, Y., Jenkins, G. D., Batzler, A. J., Snyder, K. A., Drews, M. S., Desta, Z., Flockhart, D. A., et al. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.32 · Cited by 77 · see citing works

Pharmacogenomics and Prediction of Precise Treatment Outcomes in Major Depressive Disorder

Biernacka, J. M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.09.600

Genome-wide association and DNA methylation analyses of SSRI treatment response in major depressive disorder

Lyu, N., Zhao, Q., Liu, D., Zhou, J., Zhu, X., Qi, H., Wang, H., Liu, M., Wei, M., Zhang, C., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07502-y · Cited by 3 · see citing works